We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+23.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.5M
AUM Growth
+$6.47M
Cap. Flow
-$12.7M
Cap. Flow %
-14.73%
Top 10 Hldgs %
33.2%
Holding
120
New
33
Increased
16
Reduced
36
Closed
30
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$2.09M
2
AGN
Allergan plc
AGN
+$1.67M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$1.52M
4
PFE icon
Pfizer
PFE
+$1.42M
5
UNH icon
UnitedHealth
UNH
+$1.12M

Top Sells

Rank Stock Value
1
ALLK icon
Allakos
ALLK
+$4.3M
2
UBX icon
Unity Biotechnology
UBX
+$3.43M
3
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$2.48M
4
BLK icon
Blackrock
BLK
+$1.71M
5
GDDY icon
GoDaddy
GDDY
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 49.24%
2 Miscellaneous 19.53%
3 Technology 17.92%
4 Communication Services 6.41%
5 Consumer Discretionary 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QCOM icon
1
CALL
Qualcomm
QCOM
$184B
$5.72M 6.61%
+100,300
New +$5.41M
2019 Q1
0 quarters
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$475B
$4.37M 5.05%
+24,300
New +$4.12M
2019 Q1
0 quarters
MCHP icon
3
Microchip Technology
MCHP
$40.1B
$2.58M 2.98%
62,222
+8,272
+15% +$343K
2018 Q4
1 quarter
GDDY icon
4
GoDaddy
GDDY
$13.4B
$2.45M 2.83%
32,538
-23,994
-42% -$1.69M
2016 Q4
9 quarters
ZBH icon
5
Zimmer Biomet
ZBH
$18.1B
$2.43M 2.81%
19,601
+6,573
+50% +$747K
2017 Q4
5 quarters
NTGN
6
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$2.32M 2.68%
359,125
-473,233
-57% -$2.48M
2018 Q2
3 quarters
SYK icon
7
Stryker
SYK
$113B
$2.29M 2.65%
+11,607
New +$2.09M
2019 Q1
0 quarters
UNH icon
8
UnitedHealth
UNH
$360B
$2.23M 2.58%
9,035
+4,381
+94% +$1.12M
2016 Q2
11 quarters
HUM icon
9
CALL
Humana
HUM
$49.6B
$2.18M 2.52%
+8,200
New +$2.36M
2019 Q1
0 quarters
PFE icon
10
Pfizer
PFE
$169B
$2.16M 2.5%
53,611
+35,425
+195% +$1.42M
2018 Q4
1 quarter
ALNA
11
DELISTED
Allena Pharmaceuticals
ALNA
$2.08M 2.41%
296,961
-4,928
-2% -$35.7K
2017 Q4
5 quarters
INTU icon
12
Intuit
INTU
$86.9B
$2M 2.31%
7,651
+1,271
+20% +$294K
2018 Q1
4 quarters
ELV icon
13
Elevance Health
ELV
$92.9B
$1.99M 2.3%
6,928
-1,794
-21% -$519K
2016 Q4
9 quarters
HUM icon
14
Humana
HUM
$49.6B
$1.94M 2.24%
7,287
-615
-8% -$177K
2016 Q3
10 quarters
ARNA
15
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.82M 2.1%
40,605
+1,197
+3% +$54.9K
2018 Q2
3 quarters
NYT icon
16
New York Times
NYT
$10.9B
$1.72M 1.99%
52,307
+31,430
+151% +$930K
2018 Q4
1 quarter
AGN
17
DELISTED
Allergan plc
AGN
$1.68M 1.95%
+11,505
New +$1.67M
2019 Q1
0 quarters
PYPL icon
18
PayPal
PYPL
$48.5B
$1.62M 1.87%
15,567
-8,822
-36% -$835K
2016 Q4
9 quarters
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.58M 1.83%
+5,866
New +$1.52M
2019 Q1
0 quarters
TMO icon
20
Thermo Fisher Scientific
TMO
$255B
$1.54M 1.78%
5,630
+554
+11% +$138K
2018 Q4
1 quarter
WCG
21
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.43M 1.65%
+5,300
New +$1.37M
2019 Q1
0 quarters
XYZ icon
22
Block Inc
XYZ
$46.8B
$1.32M 1.53%
17,641
+4,305
+32% +$312K
2017 Q1
8 quarters
ICUI icon
23
ICU Medical
ICUI
$4.08B
$1.32M 1.52%
5,499
+3,202
+139% +$768K
2018 Q4
1 quarter
EW icon
24
Edwards Lifesciences
EW
$49.9B
$1.28M 1.49%
20,151
-11,199
-36% -$639K
2014 Q4
17 quarters
PEN icon
25
Penumbra
PEN
$12.6B
$1.2M 1.38%
8,144
-3,202
-28% -$458K
2016 Q3
10 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Partner Investment Management held 120 positions worth $86.5M, up 8.1% from $80.1M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Partner Investment Management withdrew a net $12.7M in Q1 2019, closing 30 positions and reducing 36 holdings. Its most notable exit was Allakos, an estimated $4.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 57% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Partner Investment Management opened a new position in Stryker worth $2.29M.

  • Partner Investment Management's largest Q1 2019 buy was Stryker: 11,607 shares worth $2.29M.
  • Partner Investment Management added most to Pfizer in Q1 2019, an estimated $1.42M increase.
  • Partner Investment Management's biggest Q1 2019 reduction was Unity Biotechnology, cutting an estimated $3.43M.
  • Partner Investment Management fully exited Allakos in Q1 2019, selling an estimated $4.3M.
  • Partner Investment Management's ten largest holdings make up 33% of its $86.5M portfolio in Q1 2019.
  • Partner Investment Management opened 33 new positions and closed 30 in Q1 2019.
  • Partner Investment Management's portfolio value rose 8.1% quarter-over-quarter to $86.5M.

Based on Partner Investment Management's 13F filing for Q1 2019, filed 15 May 2019.